Skip to main content
. 2024 Feb 26;15:1280525. doi: 10.3389/fimmu.2024.1280525

Figure 6.

Figure 6

The expression of GLIPR2 predicts a more favorable immunotherapy outcome in patients. (A) Patients with high GLIPR2 expression have a better clinical response to immune therapy. (BH) Distribution of GLIPR2 expression in different clusters of cancer-resident immune cells at single cell level.